Long-acting injectable or extended-release prescription drugs; correctional facilities.
HB2473 amends Virginia’s controlled substances registration law to expressly authorize the Board of Pharmacy to register correctional facilities to maintain a floor stock of long-acting injectable or extended-release prescription drugs used to treat mental illness or substance use disorder. The bill allows these drugs to be stored in a secure area accessible only to persons licensed to administer them, even if the prescriber is not physically present, and requires each correctional facility to keep a perpetual inventory of the drugs in Schedules II through V, including monthly reconciliation and written explanations for discrepancies.
The measure also leaves in place the Board’s broader authority over controlled substances registrations for manufacturers, distributors, practitioners, animal shelters, crisis stabilization facilities, and telemedicine-related entities. It continues to require registrations based on public-interest factors, documented need, compliance with law, security, supervision, and recordkeeping, while preserving existing rules for applications, fees, and surrender of registrations after changes in ownership, location, or responsible party.
The bill narrows and clarifies the Board of Pharmacy’s registration authority by adding a specific correctional-facility category to 54.1-3423. In practice, it creates a legal pathway for jails and prisons to stock certain long-acting injectable or extended-release medications for behavioral health and substance use treatment, subject to secure storage and inventory controls. It does not broadly change controlled substances law, but it expands the list of entities that may be registered to possess controlled substances under defined conditions and imposes new compliance obligations on correctional facilities that choose to participate.
The bill appears to have been received very favorably and with little to no opposition. It advanced unanimously through subcommittee, full committee, and both chambers, with 8-0, 21-0, 97-0, 99-0, 13-0, 39-0, and 40-0 votes. The unanimous votes suggest broad bipartisan support for improving access to treatment in correctional settings and for the bill’s security and inventory safeguards.
No notable substantive contention is reflected in the available record. The main policy issue implicit in the bill is balancing expanded access to long-acting psychiatric and substance use medications in correctional facilities against diversion and security concerns, which the bill addresses through restricted access, perpetual inventory, and monthly reconciliation requirements. Because the bill moved unanimously and no committee transcript is available, there is no indication of organized opposition or disputed amendments.